Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Where appropriate, the FDA supports broader labeling of companion diagnostics.
New study finds that simple cysts should be considered normal and ignored.
A conversation with Supriya Mohile, MD
Trying to encapsulate some of the truly revolutionary recent “happenings” in diagnosing and managing prostate cancer.
Doctors with personal cancer experience are 17 percent likelier to prescribe cancer screenings to low-risk patients.
A recent report suggests reduced screening may be linked to a rise in advanced disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.